Dis-Chem, known for its competitive prices, will raise R4.8-billion when it lists on the JSE next month. Part of the money will be used to open new stores. Investors in competitor Clicks — the only pharmacy retailer listed on the JSE — will now be able to compare its performance with that of a smaller rival, but one which has performed well. Alec Abraham, an equity analyst at Sasfin Wealth, said: "Investors who wanted to have access to retail pharmacy only had the option of Clicks, which may be part of the reason why Clicks has performed so well." Over the past year the Clicks share price has gained more than 20% to R122.22. "But now with Dis-Chem as another option, you may well find some shareholders switching from Clicks to Dis-Chem," he said. Dis-Chem's revenue is R15.5-billion for the year to February 28, while Clicks had an annual revenue of R25.5-billion. Zahira Osman, a portfolio manager and head of consumer industrials at Afena Capital, said the Dis-Chem listing would provid...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.